MK 8800
Alternative Names: P04945; SCH900800Latest Information Update: 07 Jan 2014
At a glance
- Originator Merck & Co
- Class Antiparkinsonians
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 07 Jan 2014 No development reported - Preclinical for Parkinson's disease in USA (PO)
- 22 Dec 2011 Preclinical trials in Parkinson's disease in USA (PO)